467 related articles for article (PubMed ID: 12669876)
1. Detection of vascular endothelial growth factor/ vascular permeability factor in periapical lesions.
Leonardi R; Caltabiano M; Pagano M; Pezzuto V; Loreto C; Palestro G
J Endod; 2003 Mar; 29(3):180-3. PubMed ID: 12669876
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of vascular endothelial growth factor in periapical granulomas, radicular cysts, and residual radicular cysts.
Nonaka CF; Maia AP; Nascimento GJ; de Almeida Freitas R; Batista de Souza L; Galvão HC
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):896-902. PubMed ID: 18755620
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.
Couffinhal T; Kearney M; Witzenbichler B; Chen D; Murohara T; Losordo DW; Symes J; Isner JM
Am J Pathol; 1997 May; 150(5):1673-85. PubMed ID: 9137092
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions.
Brown LF; Olbricht SM; Berse B; Jackman RW; Matsueda G; Tognazzi KA; Manseau EJ; Dvorak HF; Van de Water L
J Immunol; 1995 Mar; 154(6):2801-7. PubMed ID: 7876550
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor and microvessel density around healthy and failing dental implants.
Cornelini R; Artese L; Rubini C; Fioroni M; Ferrero G; Santinelli A; Piattelli A
Int J Oral Maxillofac Implants; 2001; 16(3):389-93. PubMed ID: 11432658
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.
Middeke M; Hoffmann S; Hassan I; Wunderlich A; Hofbauer LC; Zielke A
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):386-92. PubMed ID: 12518248
[TBL] [Abstract][Full Text] [Related]
7. Expression of inducible nitric oxide synthase and heat shock proteins in periapical inflammatory lesions.
Suzuki T; Kumamoto H; Ooya K; Motegi K
J Oral Pathol Med; 2002 Sep; 31(8):488-93. PubMed ID: 12220357
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 27 expression in the epithelium of periapical lesions.
Leonardi R; Villari L; Caltabiano M; Travali S
J Endod; 2001 Feb; 27(2):89-92. PubMed ID: 11491645
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid selectively inhibits the vascular permeabilizing effect of VPF/VEGF, an early step in the angiogenic cascade.
Pal S; Iruela-Arispe ML; Harvey VS; Zeng H; Nagy JA; Dvorak HF; Mukhopadhyay D
Microvasc Res; 2000 Sep; 60(2):112-20. PubMed ID: 10964585
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of vascular endothelial growth factor in human cardiac allografts: association with rejection.
Reinders ME; Fang JC; Wong W; Ganz P; Briscoe DM
Transplantation; 2003 Jul; 76(1):224-30. PubMed ID: 12865814
[TBL] [Abstract][Full Text] [Related]
11. Mast cells in periapical lesions: potential role in their pathogenesis.
Drazić R; Sopta J; Minić AJ
J Oral Pathol Med; 2010 Mar; 39(3):257-62. PubMed ID: 20359310
[TBL] [Abstract][Full Text] [Related]
12. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.
Gosepath J; Brieger J; Lehr HA; Mann WJ
Am J Rhinol; 2005; 19(1):7-13. PubMed ID: 15794068
[TBL] [Abstract][Full Text] [Related]
13. The angiogenic peptide vascular endothelial growth factor (VEGF) is expressed in chronic sacral pressure ulcers.
Pufe T; Paulsen F; Petersen W; Mentlein R; Tsokos M
J Pathol; 2003 May; 200(1):130-6. PubMed ID: 12692851
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies.
Sioussat TM; Dvorak HF; Brock TA; Senger DR
Arch Biochem Biophys; 1993 Feb; 301(1):15-20. PubMed ID: 8442657
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of mast cell, vascular endothelial growth factor, and microvessel density in human inflammatory periapical cysts and granulomas.
Fonseca-Silva T; Santos CC; Alves LR; Dias LC; Brito M; De Paula AM; Guimarães AL
Int Endod J; 2012 Sep; 45(9):859-64. PubMed ID: 22486765
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization.
Fukuzawa M; Sugiura H; Koshinaga T; Ikeda T; Hagiwara N; Sawada T
J Pediatr Surg; 2002 Dec; 37(12):1747-50. PubMed ID: 12483647
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation.
Nagy JA; Masse EM; Herzberg KT; Meyers MS; Yeo KT; Yeo TK; Sioussat TM; Dvorak HF
Cancer Res; 1995 Jan; 55(2):360-8. PubMed ID: 7812969
[TBL] [Abstract][Full Text] [Related]
18. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.
Yeo KT; Wang HH; Nagy JA; Sioussat TM; Ledbetter SR; Hoogewerf AJ; Zhou Y; Masse EM; Senger DR; Dvorak HF
Cancer Res; 1993 Jun; 53(12):2912-8. PubMed ID: 8504432
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and vascular endothelial growth factor expression in the equine corpus luteum.
Al-zi'abi MO; Watson ED; Fraser HM
Reproduction; 2003 Feb; 125(2):259-70. PubMed ID: 12578540
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
